Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 5153184, 6 pages
http://dx.doi.org/10.1155/2016/5153184
Research Article

Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis

1The Centre for Personalized Medicine, Department of Clinical and Experimental Medicine, Division of Pediatrics, Linkoping University, Linkoping, Sweden
2Bioinformatics, Department of Physics, Chemistry and Biology, Linkoping University, SE-581 83 Linkoping, Sweden
3Division of Neuro and Inflammation Science, Department of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
4Department of Otorhinolaryngology in Linkoping, Anaesthetics, Operations and Specialty Surgery Center, Region Ostergotland, Sweden
5Futurum-Academy for Health and Care, County Council of Jonkoping, Jonkoping, Sweden
6Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

Received 23 September 2016; Revised 18 November 2016; Accepted 29 November 2016

Academic Editor: Andréia M. Cardoso

Copyright © 2016 Lina Mattson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Jay and K. C. Nadeau, “Immune mechanisms of sublingual immunotherapy,” Current Allergy and Asthma Reports, vol. 14, no. 11, p. 473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. M. Kündig, P. Johansen, M. F. Bachmann, L. O. Cardell, and G. Senti, “Intralymphatic immunotherapy: time interval between injections is essential,” Journal of Allergy and Clinical Immunology, vol. 133, no. 3, pp. 930–931, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Nestor, E. Dadfar, J. Ernerudh et al., “Sublingual immunotherapy alters expression of IL-4 and its soluble and membrane-bound receptors,” Allergy, vol. 69, no. 11, pp. 1564–1566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Pritchard, O. J. White, J. G. Burel, and J. W. Upham, “Innate interferons inhibit allergen and microbial specific TH2 responses,” Immunology and Cell Biology, vol. 90, no. 10, pp. 974–977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. Platanias, “Mechanisms of type-I- and type-II-interferon-mediated signalling,” Nature Reviews Immunology, vol. 5, no. 5, pp. 375–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Osokine, L. M. Snell, C. R. Cunningham et al., “Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 20, pp. 7409–7414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Zhang, C. E. Nestor, S. Zhao et al., “Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1,” Journal of Allergy and Clinical Immunology, vol. 132, no. 4, pp. 1005–1008, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Benson, L. Carlsson, M. Adner et al., “Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1137–1143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Wang, S. Chavali, R. Mobini et al., “A pathway-based approach to find novel markers of local glucocorticoid treatment in intermittent allergic rhinitis,” Allergy, vol. 66, no. 1, pp. 132–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Ritchie, B. Phipson, D. Wu et al., “Limma powers differential expression analyses for RNA-sequencing and microarray studies,” Nucleic Acids Research, vol. 43, no. 7, article e47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Benson, M. A. Langston, M. Adner, B. Andersson, Å. Torinssson-Naluai, and L. O. Cardell, “A network-based analysis of the late-phase reaction of the skin,” Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 220–225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Mobini, B. A. Andersson, J. Erjefält et al., “A module-based analytical strategy to identify novel disease-associated genes shows an inhibitory role for interleukin 7 Receptor in allergic inflammation,” BMC Systems Biology, vol. 3, article no. 19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Passalacqua, V. Garelli, F. Sclifò, and G. W. Canonica, “Sublingual immunotherapy for allergic rhinitis and conjunctivitis,” Immunotherapy, vol. 5, no. 3, pp. 257–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Irani, R. A. Saleh, M. Jammal, and F. Haddad, “High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study,” International Forum of Allergy and Rhinology, vol. 4, no. 10, pp. 802–807, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Gustafsson, D. R. Gawel, L. Alfredsson et al., “A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases,” Science Translational Medicine, vol. 7, no. 313, Article ID 313ra178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Bosco, K. L. McKenna, M. J. Firth, P. D. Sly, and P. G. Holt, “A network modeling approach to analysis of the Th2 memory responses underlying human atopic disease,” Journal of Immunology, vol. 182, no. 10, pp. 6011–6021, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Pestka, J. A. Langer, K. C. Zoon, and C. E. Samuel, “Interferons and their actions,” Annual Review of Biochemistry, vol. 56, pp. 727–777, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Pestka, C. D. Krause, and M. R. Walter, “Interferons, interferon-like cytokines, and their receptors,” Immunological Reviews, vol. 202, pp. 8–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Pestka, “The human interferon-α species and hybrid proteins,” Seminars in Oncology, vol. 24, no. 3, pp. S9-4–S9-17, 1997. View at Google Scholar · View at Scopus
  20. S. Pestka, S. V. Kotenko, G. Muthukumaran, L. S. Izotova, J. R. Cook, and G. Garotta, “The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor,” Cytokine & Growth Factor Reviews, vol. 8, no. 3, pp. 189–206, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. E. A. Bach, M. Aguet, and R. D. Schreiber, “The IFNγ receptor: a paradigm for cytokine receptor signaling,” Annual Review of Immunology, vol. 15, pp. 563–591, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Irizarry, C. Wang, Y. Zhou, and T. P. Speed, “Gene set enrichment analysis made simple,” Statistical Methods in Medical Research, vol. 18, no. 6, pp. 565–575, 2009. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus